Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kurtoglu Metin
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Singer Michael
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jewell Christopher M
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Timothy A. Springer(37.1%),TAS Partners LLC(2.2%), etc.
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SPRINGER TIMOTHY A
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kurtoglu Metin
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Miljkovic Milos
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jewell Christopher M
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kalayoglu Murat
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Hoge Elizabeth
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.9%), etc.
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Timothy A. Springer(37.6%),TAS Partners LLC(2.4%), etc.
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SPRINGER TIMOTHY A
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Timothy A. Springer(36.7%),TAS Partners LLC(11.7%), etc.
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SPRINGER TIMOTHY A
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SPRINGER TIMOTHY A
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BARABE TIMOTHY C
Cartesian Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(12.734%),Abigail P. Johnson(12.734%)
Cartesian Therapeutics | D: Filing D
Cartesian Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(2.8%),Invus Public Equities Advisors, LLC(2.8%), etc.
No Data
No Data